New COVID-19 Variant Defeats Plasma Treatment, MABs, May Reduce Vaccine Efficacy New COVID-19 Variant Defeats Plasma Treatment, MABs, May Reduce Vaccine Efficacy
The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may reduce the efficacy of current vaccines, say scientists.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: African Health | COVID-19 | Infectious Diseases | Intensive Care | South Africa Health | Vaccines